Martin Höglund - Concepedia

Author

Martin Höglund

Also Known As

L Wennström, M Hglund, M Höglund, M. Hoglund, M. Höglund, Martin Hoglund, Martin Höglund, Martin Höglund, Rose, Samuel A.

269

Publications

12.5K

Citations

H-Index

102

Concepts

All Affiliations

Uppsala University Hospital Uppsala University Karolinska University Hospital Karolinska Institutet Skåne University Hospital

About

Martin Höglund is an author at Uppsala University Hospital specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	2.1K
2	Health Sciences	11	12	554
3	Public Health	6	6	570
4	Natural Sciences	2	2	117
5	Allergy	1	1	14

Martin Höglund

108

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence Giulio Genovese, Anna K. Kähler, Robert E. Handsaker, New England Journal of Medicine	2014	3.4K
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf, Blood	2008	983
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population Hannah Bower, Magnus Björkholm, Paul W. Dickman, Journal of Clinical Oncology	2016	853
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán, Blood	2008	437
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry Sylvain Lehmann, Lotta Höglund Carlsson, P Antunović, Leukemia Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaPrognosisHematology	2011	349
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy Satu Mustjoki, Marja Ekblom, T. Petteri Arstila, Leukemia MedicineMalignant Blood DisorderImmunologyImmune Checkpoint InhibitorCell Biology	2009	316
Acute myeloid leukemia in the real world: why population-based registries are needed Gunnar Juliusson, Vladimir Lazarević, Ann‐Sofi Hörstedt, Blood	2012	300
Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: <scp>A</scp> report from the <scp>S</scp>wedish <scp>A</scp>cute <scp>L</scp>eukemia <scp>R</scp>egistry Erik Hulegårdh, Christer Nilsson, Vladimir Lazarević, American Journal of Hematology	2014	271
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, Clinical Cancer Research	2018	250
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums, Leukemia	2016	239

Page 1